Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 31Esophageal Squamous Cell Carcinoma 17Carcinoma, Squamous Cell 5Adenocarcinoma 3Neoplasms 2Postoperative Complications 1Pathologic Complete Response 1Pain, Postoperative 1Lymphatic Metastasis 1Loco-regional Esophageal Cancer 1Deglutition Disorders 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Anastomotic Leak 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Esophagectomy × Clear all
NCT00937456 2026-04-22

Open Versus Laparoscopically-assisted Esophagectomy for Cancer

University Hospital, Lille

Phase NA Completed
207 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms

NCT02426879 2021-09-30

Node

UMC Utrecht

Phase NA Completed
20 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡